Stilnox CR now available in Korea

Published: 2006-12-04 07:00:00

Updated: 2006-12-04 07:00:00

Sanofi-aventis Korea announced on December 1 that Stilnox CR (zolpidem tartrate extended-release tablets), a new extended-release formulation of the best-selling prescription sleep aid Stilnox, is now available by prescription in Korea for the treatment of insomnia.

Stilnox CR is non-narcotic ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK